MedTrace Logo

Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.

NCT03031210 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 1370

Last updated 2025-05-14

No results posted yet for this study

Summary

The aim of this study will be to evaluate whether a twice-daily antibiotic regimen is non-inferior to a thrice-daily regimen for the treatment of non-severe community acquired pneumonia in children presenting at a paediatric Emergency Department (ED).

Conditions

  • Community-acquired Pneumonia

Interventions

DRUG

Amoxicillin

(90 mg/kg/day) twice daily

Sponsors & Collaborators

  • St. Justine's Hospital

    lead OTHER

Principal Investigators

  • Jocelyn Gravel, MD · Sainte-Justine Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-11
Primary Completion
2027-06-01
Completion
2027-06-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03031210 on ClinicalTrials.gov